CardioComm Planning Bluetooth HeartCheck™ PEN for Android, Apple Smartphones

CardioComm Solutions Inc. (TSXV:EKG) announced plans to introduce a Bluetooth HeartCheck™ PEN for wireless connectivity to Android and Apple Inc. (NASDAQ:AAPL) smartphones by the first quarter of 2016.

The company is a global medical provider of electrocardiogram (ECG) acquisition and management software and states that it is the first to bring ECGs to the North American consumer and over-the-counter markets.

As quoted in the press release:

The Company has completed the development and testing of a pre-production version of the Bluetooth HeartCheck™ ECG PEN and a Smartphone application that will wirelessly connect the Bluetooth ECG PEN to the Company’s SMART Monitoring ECG service. With the review of FDA and Health Canada requirements completed and confirming a Bluetooth enabled version of the HeartCheck™ ECG PEN can be sold under the Company’s current and existing medical device approvals, the release of the wireless version of the HeartCheck™ ECG PEN can occur with material time and cost savings. The Bluetooth HeartCheck™ ECG PEN model will retain the same form factor and use-advantages as the current ECG PEN version. It will allow ECGs to be viewed on the device while heart rhythm recordings are taken and for the storage and replaying of up to 20 ECGs. In addition to wireless communication, the Company will maintain the device’s USB connectivity to a Windows-based PC which is critical where cellular coverage may be unreliable.

The ability to connect to Smartphones will provide CardioComm Solutions access to an expansive mobile health consumer market not previously marketed to. Two advantages and major product differentiators of the Bluetooth HeartCheck™ ECG PEN versus other Smartphone-connected ECG monitoring devices are:

1. Use of the device is not dependent on a Smartphone: ECG recordings by other devices are not possible if they are not physically near the Smartphone, if the phone is out of power or if cellular reception is not available; and
2. No physician prescription is required as a condition to be able to see an ECG report.

Click here to read the full CardioComm Solutions Inc. (TSXV:EKG) press release.